These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies. Jenkinson AD, Al-Mufti RA, Mohsen Y, Berry MJ, Wells C, Carpenter R. Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487 [Abstract] [Full Text] [Related]
6. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material. Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H. Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540 [Abstract] [Full Text] [Related]
9. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival. Dieterich M, Hartwig F, Stubert J, Klöcking S, Kundt G, Stengel B, Reimer T, Gerber B. Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611 [Abstract] [Full Text] [Related]
17. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma. Sakr R, Antoine M, Barranger E, Dubernard G, Salem C, Daraï E, Uzan S. Breast J; 2008 Oct; 14(1):55-60. PubMed ID: 18186866 [Abstract] [Full Text] [Related]
18. Optimal management of ductal carcinoma in situ of the breast. Sakorafas GH, Farley DR. Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563 [Abstract] [Full Text] [Related]
19. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA. Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1514-21. PubMed ID: 16005576 [Abstract] [Full Text] [Related]
20. LEA.135 expression: identifies low-risk patients with breast ductal carcinoma in situ. Baltayan A, Naritoku WY, Chaiwun B, Tsao-Wei DD, Groshen S, Hern RA, Gusterson BA, Taylor CR, Imam SA. Anticancer Res; 2002 Dec 01; 22(5):2933-7. PubMed ID: 12530020 [Abstract] [Full Text] [Related] Page: [Next] [New Search]